BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14661)

  • 1. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
    Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
    Feely J
    Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of thyroid dysfunction on propranolol kinetics.
    Riddell JG; Neill JD; Kelly JG; McDevitt DG
    Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
    Meier J
    Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug pharmacokinetics in thyroid dysfunction.
    Rodighiero V
    Minerva Endocrinol; 1985; 10(2):97-113. PubMed ID: 2415808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 7. No enhanced elimination of propranolol in patients with hyperthyroidism.
    Ishizaki T; Masuno M; Tawara K
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biotransformation and pharmacokinetics of beta-receptor blockaders].
    Pfeifer S; Zimmer C
    Pharmazie; 1975 Oct; 30(10):625-33. PubMed ID: 685
    [No Abstract]   [Full Text] [Related]  

  • 9. The uptake and overflow of radiolabelled beta-adrenoceptor blocking agents by the isolated vas deferens of the rat.
    Lewis MJ
    Br J Pharmacol; 1977 Aug; 60(4):595-600. PubMed ID: 20192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biologic distribution of radioiodinated beta-adrenergic antagonists.
    Hanson RN; Holman BL; Davis MA
    J Med Chem; 1978 Aug; 21(8):830-3. PubMed ID: 29126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dosage of digitalis glycosides and beta blockers in renal insufficiency].
    Ohnhaus EE
    Med Klin; 1976 Oct; 71(44):1867-72. PubMed ID: 11399
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: An investigation of the rat in situ absorption model using practolol and propranolol.
    Taylor DC; Grundy RU
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():65P. PubMed ID: 2741
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
    Shand DG
    Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
    [No Abstract]   [Full Text] [Related]  

  • 17. Disposition in rats and mice of chloropractolol, a new beta-blocking agent.
    Godeneche D; Pilichowski JF; Meyniel G
    Xenobiotica; 1980 Sep; 10(9):725-33. PubMed ID: 6108651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of some selected beta-adrenergic blocking agents--oxidation with N-bromosuccinimide.
    Trieff NM; Venkatasubramanian N; Sadagopa Ramanujam VM; Young TR; Levy B
    Tex Rep Biol Med; 1976; 34(2-4):315-29. PubMed ID: 20674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and management of poisoning with beta-adrenergic blocking agents.
    Weinstein RS
    Ann Emerg Med; 1984 Dec; 13(12):1123-31. PubMed ID: 6150667
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.